ClinicalTrials.govpublic full text
The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A
nafld, non-alcoholic fatty liver disease, isoflavones, soy foods, fgf21, liver steatosis, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862692
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.